Bonazzi, E.; Maniero, D.; Lorenzon, G.; Bertin, L.; Bray, K.; Bahur, B.; Barberio, B.; Zingone, F.; Savarino, E.V.
Comparing Point-of-Care Technology to ELISA Testing for Infliximab and Adalimumab Levels in Adult Inflammatory Bowel Disease Patients: A Prospective Pilot Study. Diagnostics 2024, 14, 2140.
https://doi.org/10.3390/diagnostics14192140
AMA Style
Bonazzi E, Maniero D, Lorenzon G, Bertin L, Bray K, Bahur B, Barberio B, Zingone F, Savarino EV.
Comparing Point-of-Care Technology to ELISA Testing for Infliximab and Adalimumab Levels in Adult Inflammatory Bowel Disease Patients: A Prospective Pilot Study. Diagnostics. 2024; 14(19):2140.
https://doi.org/10.3390/diagnostics14192140
Chicago/Turabian Style
Bonazzi, Erica, Daria Maniero, Greta Lorenzon, Luisa Bertin, Kurtis Bray, Bayda Bahur, Brigida Barberio, Fabiana Zingone, and Edoardo Vincenzo Savarino.
2024. "Comparing Point-of-Care Technology to ELISA Testing for Infliximab and Adalimumab Levels in Adult Inflammatory Bowel Disease Patients: A Prospective Pilot Study" Diagnostics 14, no. 19: 2140.
https://doi.org/10.3390/diagnostics14192140
APA Style
Bonazzi, E., Maniero, D., Lorenzon, G., Bertin, L., Bray, K., Bahur, B., Barberio, B., Zingone, F., & Savarino, E. V.
(2024). Comparing Point-of-Care Technology to ELISA Testing for Infliximab and Adalimumab Levels in Adult Inflammatory Bowel Disease Patients: A Prospective Pilot Study. Diagnostics, 14(19), 2140.
https://doi.org/10.3390/diagnostics14192140